Degeneration of amyloid-ß fibrils caused by exposure to low-temperature atmospheric-pressure plasma in aqueous solution by Takai Eisuke et al.
Degeneration of amyloid-s fibrils caused by
exposure to low-temperature
atmospheric-pressure plasma in aqueous
solution
著者 Takai Eisuke, Ohashi Gai, Yoshida Tomonori,
Sorgjerd Karin Margareta, Zako Tamotsu, Maeda
Mizuo, Kitano Katsuhisa, Shiraki Kentaro
journal or
publication title
Applied physics letters
volume 104
number 2
page range 023701
year 2014-01
権利 (C) 2014 AIP Publishing LLC.　This article may
be downloaded for personal use only. Any other
use requires prior permission of the author
and the American Institute of Physics.The
following article appeared in Appl. Phys.
Lett. 104, 023701 (2014) and may be found at
http://dx.doi.org/10.1063/1.4861842.
URL http://hdl.handle.net/2241/121018
doi: 10.1063/1.4861842
Degeneration of amyloid-ß fibrils caused by exposure to low-temperature atmospheric-
pressure plasma in aqueous solution
Eisuke Takai, Gai Ohashi, Tomonori Yoshida, Karin Margareta Sörgjerd, Tamotsu Zako, Mizuo Maeda,
Katsuhisa Kitano, and Kentaro Shiraki 
 
Citation: Applied Physics Letters 104, 023701 (2014); doi: 10.1063/1.4861842 
View online: http://dx.doi.org/10.1063/1.4861842 
View Table of Contents: http://scitation.aip.org/content/aip/journal/apl/104/2?ver=pdfcov 
Published by the AIP Publishing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 This article is copyrighted as indicated in the article. Reuse of AIP content is subject to the terms at: http://scitation.aip.org/termsconditions. Downloaded to IP:
130.158.56.101 On: Fri, 14 Mar 2014 01:04:13
Degeneration of amyloid-ß fibrils caused by exposure to low-temperature
atmospheric-pressure plasma in aqueous solution
Eisuke Takai,1 Gai Ohashi,1 Tomonori Yoshida,2,3 Karin Margareta S€orgjerd,2,a)
Tamotsu Zako,2 Mizuo Maeda,2,3 Katsuhisa Kitano,4 and Kentaro Shiraki1,b)
1Faculty of Pure and Applied Science, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8573,
Japan
2Bioengineering Laboratory, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
3Department of Advanced Materials Science, School of Frontier Sciences, The University of Tokyo, 5-1-5,
Kashiwanoha, Kashiwa, Chiba 227-8561, Japan
4Center for Atomic and Molecular Technologies, Graduate School of Engineering, Osaka University,
Osaka 565-0871, Japan
(Received 22 October 2013; accepted 26 December 2013; published online 13 January 2014)
Low-temperature atmospheric-pressure plasma was applied to degenerate amyloid-ß (Aß) fibrils,
which are a major component of neuritic plaque associated with Alzheimer’s disease (AD). We
showed that an Aß fibril exposed to a low-frequency (LF) plasma jet in aqueous solution retained
its morphology, molecular weight, and cytotoxicity, but, intriguingly, decreased in protease
resistance and ß-sheet content. These results suggested that an LF plasma jet could be utilized
for the treatment of AD to eliminate neuritic plaque by accelerating the proteolysis of Aß fibrils.
VC 2014 AIP Publishing LLC. [http://dx.doi.org/10.1063/1.4861842]
Low-temperature atmospheric-pressure plasma (LTAPP)
generates reactive oxygen species (ROS),1 typically hydroxyl
radicals (OH),2–6 superoxide anion radicals (O2),7 hydro-
peroxyl radicals (HOO),8 singlet oxygen (1O2), and atomic
oxygen (O)9 in the gas phase. It has been reported that the
plasma processing of solids is useful in producing surface
coatings for biomedical materials.10–12 In contrast, once
LTAPP is exposed to a solution, advanced reaction fields are
induced inside the liquid because some of the plasma-induced
ROS diffuse into the solution. This feature of LTAPP process-
ing allows the exploitation of a type of chemical reactions in
solution.13–15 Because organisms also present aqueous condi-
tions, this phenomenon is expected to inform the development
of plasma medicines16,17 for cancer,18–21 glioma,22 dentistry,23
blood coagulation,24 disruption of the human hepatocyte cyto-
skeleton,25 sterilization,26–35 and Parkinson’s disease.36 In this
letter, we examine the application possibilities of LTAPP for
the treatment of Alzheimer’s disease (AD), which is a pro-
gressive neurodegenerative disorder characterized by memory
loss and dementia that was reported by Alois Alzheimer in
1906; it is the most common cause of dementia in elderly peo-
ple, accounting for more than 15  106 cases worldwide.37,38
For the present study, a low-frequency (LF) plasma jet
was used for the LTAPP processing in a manner similar to
that described in our previous study.8,34,39 The plasma shape
was elongated from the end of a quartz glass tube, in which
helium gas flowed, by the application of an alternating-
current high voltage (ranging from 3.5 to þ5.0 kV at a fre-
quency of 13.9 kHz) to a single-sided electrode (Fig. 1(a)).
Helium plasma with a low gas temperature was generated in
an elongated shape (Fig. 1(b)). The discharge power of the
plasma was 3 W. The LF plasma jet was generated inside an
airtight chamber from its center port. The ambient gas of the
chamber could be controlled using the other oxygen (O2) gas
supply port connected to the side of the plasma-jet port. The
flow rates of He and O2 gas were 0.50 and 0.15 l/min, respec-
tively. Various active oxygen species produced from the O2
gas by the plasma were supplied to the solution.
Amyloid fibrils of human protein Aß were prepared
in vitro. Briefly, lyophilized Aß1–40 from Peptide Institute
Inc., Osaka, Japan was dissolved in phosphate-buffered sa-
line (PBS; 100 mM NaCl, 50 mM Na-phosphate buffer at pH
7.4), and then the sample was incubated at 37 C for 5 days.
As expected, typical mature Aß fibrils were formed, which
are characterized by (i) a sigmoidal evolution of the
FIG. 1. Plasma jet generated using helium gas flowing through quartz glass
tube. (a) Schematic representation of the plasma-jet system with sample so-
lution. The plume-like structure of the plasma extends toward the surface of
the sample solution. (b) Photograph of the plasma jet.
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Thioflavine T (ThT) fluorescent intensity with a lag time of
1–2 days (Fig. S1a in supplementary material48), (ii) linear
protein aggregates visualized via transmission electron micros-
copy (TEM) with stain (Fig. S1a, inset in supplementary mate-
rial48), and (iii) a ß-sheet structure identified by a negative
peak at 218 nm in the far-UV circular dichroism (CD) spectra
(Fig. S1b in supplementary material48). The Aß fibril solution
was treated with an LF plasma jet (Fig. 1). Then, the plasma-
exposed Aß fibrils were analyzed using several biochemical
and biophysical methods to detect changes in physiological ac-
tivity. These experimental procedures and systems are
described in detail in the supplementary material.48
The morphology, length, aggregation extent, and molec-
ular weight of the plasma-exposed fibrils were investigated.
Figures 2(a) and 2(b) show TEM images of fibrils that were
exposed to the plasma for 0 and 30 min, respectively. The
Aß fibrils that were exposed for 30 min were observed to
be non-branched fibrils of more than 1 lm in length, similar
to the untreated fibrils (0 min). The length distributions of
the plasma-exposed fibrils for 0 and 30 min were almost
identical, indicating that the Aß fibrils were not fragmented
by plasma exposure in solution (Figs. 2(c) and 2(d)). This
result was supported by a native poly-acrylamide gel electro-
phoresis (PAGE)/Western-blotting analysis, which showed
that there were no soluble oligomeric species in the plasma-
exposed fibril samples (Fig. 2(e)). The aggregation extent of
the Aß fibrils was monitored via light scattering at 350 nm,
which is sensitive to the number and size of aggregates pres-
ent in a solution, as reported previously.40,41 The light-
scattering intensity was proportional to the concentration of
Aß, but it was unchanged by the plasma exposure (Fig. 2(f)).
These results demonstrated that the morphology, length, mo-
lecular weight, and aggregation extent of the Aß fibrils were
unchanged by plasma exposure for a duration of several
minutes. In contrast, it has been reported that amyloid fibrils
of a-synuclein were fragmented by 6 min of exposure to a
low-temperature plasma jet in solution.36 These differing
results may be attributable to the difference in the structural
stability of the amyloid fibrils.42
The cytotoxicity of the plasma-exposed Aß fibrils on a
rat pheochromocytoma PC12 cell was examined using an 3-
(4,5-di-methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay, as previously described.43 First, we demon-
strated that the plasma-exposed PBS without Aß also exhib-
ited cytotoxicity (Fig. 3(a)) because of the hydrogen
peroxide generated by a plasma-inactivated culture cell.18 To
overcome this problem, catalase, which is an enzyme that
catalyzes the decomposition of hydrogen peroxide to water
and oxygen, was added to the sample solution to avoid the
confounding influence of hydrogen peroxide in the cytotox-
icity assay (Fig. 3(a)). Figure 3(b) shows the cytotoxicity of
plasma-exposed Aß fibrils with the inclusion of catalase,
FIG. 2. Characterization of Ab fibrils exposed to an LF plasma jet. Morphology of Ab fibrils (a) before and (b) after the plasma exposure (30 min) as imaged
via TEM. The scale bars represent 200 nm. Contour-length distribution of Ab fibrils (c) before and (d) after the plasma exposure, calculated from TEM images.
The sampling numbers were 150 in (c) and 171 in (d). (e) Native PAGE/Western-blotting analysis of Ab fibrils exposed to an LF plasma jet using mouse
monoclonal anti-Ab (6E10). Unincubated Ab monomers were used as a control. (f) Light scattering at 350 nm as a function of the Ab concentration (closed
circles, top axis) and the plasma-exposure time (open circles, bottom axis).
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which was added after plasma exposure. The Aß fibrils with-
out plasma exposure exhibited high cytotoxicity. The Aß
fibrils that were exposed to plasma for 5–20 min also exhib-
ited high cytotoxicity. Thus, it could be concluded that the
cytotoxicity of the Aß fibrils was not changed by plasma
exposure for a duration of several minutes.
The protease-resistant property of the plasma-exposed
fibrils was examined using trypsin, which is a serine protease
that cleaves peptide chains at the carboxyl end of the amino
acids lysine and arginine.44 Figure 4(a) shows the light-
scattering intensity of the plasma-exposed fibrils after the
trypsin treatment. The light-scattering intensity of the Aß
fibrils decreased with increasing plasma-exposure time, indi-
cating that the protease resistance of the Aß fibrils was
decreased by the plasma treatment. The decrease of the pro-
tease resistance of the plasma-treated Aß fibrils was con-
firmed by using other proteases (Fig. S2 in supplementary
material48). The degradation of the plasma-exposed fibrils by
trypsin was confirmed via atomic force microscopy (AFM)
(Figs. 4(b) and 4(c)). The degraded Aß fibrils were primarily
observed as spherical aggregates (Fig. 4(b)), which may con-
sist of insoluble peptides of Aß formed via proteolysis. In
contrast, the Aß fibrils that were not exposed to the plasma
remained as fibrillar aggregates even after the trypsin treat-
ment (Fig. 4(c)). No aggregates of the Aß peptides before
incubation were observed (Fig. 4(d)). These results demon-
strated that the protease resistance of the Aß fibrils was
degraded by plasma exposure.
To elucidate the mechanism of the loss of the protease
resistance of the Aß fibrils caused by plasma exposure, we
examined the structural properties of the plasma-exposed Aß
fibrils via far-UV CD spectroscopy to determine the ß-sheet
content and via fluorescence assay with thioflavin T (ThT) to
determine the amount of accumulated cross-ß structure and
8-anilino-1-naphthalenesulfonic acid (ANS) to understand
the surface hydrophobicity (Fig. 5). The peak at 218 nm in
the CD spectrum decreased in intensity with increasing
plasma-exposure time, indicating that the regular cross-ß
structure of the Aß fibrils45 was destroyed by plasma expo-
sure. The intensity at 218 nm of the plasma exposed Ab
fibrils was unchanged even after incubation at 37 C for
24–72 h (Fig. 5(a), inset), indicating that there is no recovery
of Ab fibrils from the damages unlike living cells. The ThT
fluorescence intensity decreased with increasing plasma-
exposure time (Fig. 5(b)), which is consistent with the results
from the CD spectra (Fig. 5(a)), indicating the unfolding of
the ß-sheet core in the Aß fibrils as a result of the plasma
exposure. The ANS fluorescence of the plasma-exposed Aß
fibrils was quenched (Fig. 5(c)), which indicates that the sur-
face hydrophobicity of the Aß fibrils was decreased by the
plasma exposure. These results suggest that the degeneration
of Aß fibrils induced by plasma exposure might cause the
loss of their protease-resistant property.
Plasma exposure in solution induces chemical reaction
fields not only on the surface of the liquid but also inside the
liquid itself because of the diffusion of ROS generated in the
gas phase. These species should react with Aß fibrils. In fact,
some amino-acid residues of Aß peptides, such as methio-
nine, tyrosine, and histidine, are oxidized by the ROS gener-
ated via laser irradiation in solution.46 We have previously
reported that chemical modifications of amino-acid residues
induced the denaturation and inactivation of proteins via
plasma exposure in solution.39 Therefore, it is plausible that
chemical reactions of the amino-acid residues with the ROS
generated by plasma may result in the degeneration of Aß
fibrils and the loss of their protein-resistant property.
It was demonstrated that the protease resistance, ß-sheet
structure, and surface properties of Aß fibrils were changed
by LTAPP processing in aqueous solution while the mor-
phology, length, and cytotoxicity remained unchanged. In a
FIG. 3. Cytotoxicity assays of the plasma-treated samples with PC12 cells using an MTT assay. (a) Cytotoxicity assays of plasma-treated PBS without Ab in
the absence (open circles) or presence (closed circles) of 2 lg/ml of catalase. The catalase was added after plasma exposure and before the cytotoxicity assays.
(b) Cytotoxicity assays of Ab as a function of the exposure time with the addition of 2 lg/ml of catalase after plasma exposure.
FIG. 4. Evaluation of the protease resistance of Ab fibrils exposed to an LF
plasma jet. (a) Light-scattering intensity at 350 nm of Ab fibrils incubated
with trypsin for 24 h as a function of the plasma-exposure time. The light-
scattering intensity of 100% was defined by the measurement of a sample of
unexposed Ab fibrils without trypsin digestion. AFM images of the Ab
fibrils that were exposed to the plasma for (b) 30 min and (c) 0 min and incu-
bated with trypsin for 24 h. (d) AFM image of the Ab before incubation. The
scale bars represent 200 nm.
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previous study, the degradation of Aß fibrils induced by
direct LTAPP treatment on a solid surface has been
reported.47 Any species can act in direct LTAPP treatment;
on the other hand, only soluble and long-lived species, such
as HOO, can attack in LTAPP processing in aqueous solu-
tion.34 Therefore, the seemingly contradictory results of the
two studies might be attributable to the difference in the
amount and type of ROS attacking the Aß fibrils.
In conclusion, we demonstrated that LTAPP treatment
caused the degeneration of Aß fibrils, which are a major com-
ponent of the neuritic plaque associated with AD, in terms of
accumulated ß-sheet content and protease resistance, while the
morphology, contour length, and cytotoxicity of the Aß fibrils
remained unchanged. The loss of the protease resistance of the
Aß fibrils caused by plasma exposure suggests prospects for
utilizing LTAPP for the elimination of neuritic plaque associ-
ated with AD by accelerating the proteolysis of Aß fibrils.
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